Signature Estate & Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History

Signature Estate & Investment Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$448K	Hold	1,832	–	–	0.01%	456
2026 Q1	$310K	Hold	1,832	–	–	0.01%	529
2025 Q4	$335K	Hold	1,832	–	–	0.01%	480
2025 Q3	$222K	Buy	+1,832	New	+$206K	﹤0.01%	555
2025 Q2	–	Sell	-1,832	Closed	-$214K	–	580
2025 Q1	$214K	Sell	1,832 -800	-30%	-$91.1K	0.01%	517
2024 Q4	$223K	Hold	2,632	–	–	0.01%	485
2024 Q3	$237K	Hold	2,632	–	–	0.01%	463
2024 Q2	$212K	Hold	2,632	–	–	0.01%	478
2024 Q1	$210K	Sell	2,632 -405	-13%	-$34K	0.01%	167
2023 Q4	$242K	Hold	3,037	–	–	0.01%	166
2023 Q3	$212K	Buy	+3,037	New	+$227K	0.01%	165
2023 Q1	–	Sell	-2,632	Closed	-$203K	–	176
2022 Q4	$203K	Buy	+2,632	New	+$157K	0.01%	178
2021 Q1	–	Sell	-2,632	Closed	-$214K	–	165
2020 Q4	$214K	Buy	+2,632	New	+$197K	0.01%	152
2020 Q3	–	Sell	-2,632	Closed	-$217K	–	151
2020 Q2	$217K	Buy	+2,632	New	+$203K	0.02%	132
2020 Q1	–	Sell	-2,632	Closed	-$272K	–	133
2019 Q4	$272K	Buy	+2,632	New	+$106K	0.02%	144

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Signature Estate & Investment Advisors's AXSM Position: Q2 2026 in Review

Signature Estate & Investment Advisors held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 1,832 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #456.

Signature Estate & Investment Advisors first reported a position in AXSM in Q4 2019 and has held it in 15 quarters since. 190 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Signature Estate & Investment Advisors held 1,832 shares of Axsome Therapeutics worth $448K as of Q2 2026.
Signature Estate & Investment Advisors left its Axsome Therapeutics share count unchanged in Q2 2026.
Axsome Therapeutics made up 0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #456 holding.
Signature Estate & Investment Advisors first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 15 quarters since.
190 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.